Nxstage Medical (NXTM) 19.40 $NXTM
NxStage Kidney Care Brings Flexible Dialysis Therapy Options to North Orlando
PR Newswire - Wed Apr 22, 7:00AM CDT
NxStage® Kidney Care, Inc. (NxKC), a subsidiary of NxStage® Medical, Inc. (Nasdaq: NXTM), today announced the opening of its North Orlando, Florida dialysis center. The new clinic is owned and operated in partnership with Central Florida Kidney Centers, a nonprofit dialysis provider serving central Florida for over 42 years. Conveniently located in Casselberry, the center boasts a team of highly-trained medical personnel dedicated to providing high-quality, personalized and compassionate care to dialysis patients and their loved ones.
NXTM: 19.40 (+0.04)
Insider Trading Alert - AGIO, NXTM And EBIX Traded By Insiders
at The Street - Mon Apr 20, 9:48AM CDT
Stocks with insider trader activity include AGIO, NXTM and EBIX
NXTM: 19.40 (+0.04), EBIX: 29.77 (-0.21), AGIO: 107.04 (+3.28)
NxStage Medical Opens New Dialysis Center in Pittsburgh - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 1:00PM CDT
NxStage Medical Inc.'s (NXTM) Monroeville dialysis center will offer flexible therapies and high-quality personalized care to dialysis patients and their families.
SRDX: 26.53 (+0.03), NXTM: 19.40 (+0.04), CSII: 37.22 (-2.00), LMAT: 8.60 (+0.03)
NxStage Kidney Care Brings Dialysis Options to Pittsburgh Area
PR Newswire - Tue Apr 14, 7:00AM CDT
NxStage® Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), today announced the opening of its Monroeville, Pennsylvania dialysis center, offering local patients several flexible therapy options. Conveniently located in Allegheny County, the NxStage Kidney Care Pittsburgh team is comprised of highly trained medical staff committed to providing dialysis patients with high quality, personalized and compassionate care.
NXTM: 19.40 (+0.04)
Insider Trading Alert - KMG, NXTM And DRI Traded By Insiders
at The Street - Fri Apr 10, 9:05AM CDT
Stocks with insider trader activity include KMG, NXTM and DRI
NXTM: 19.40 (+0.04), KMG: 30.00 (unch), DRI: 67.01 (+1.20)
NxStage® to Report First Quarter 2015 Financial Results
PR Newswire - Tue Apr 07, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the first quarter ended March 31, 2015, on Wednesday, May 6, 2015, before the opening of the financial markets.
NXTM: 19.40 (+0.04)
NxStage Medical Opens New Dialysis Center in Maryland - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 5:31PM CDT
NxStage Kidney Care Inc., a subsidiary of NxStage Medical Inc. (NXTM) opened a dialysis center in Greenbelt, MD, focused on providing flexible therapies and high-quality personalized care to dialysis patients and their families.
SRDX: 26.53 (+0.03), NXTM: 19.40 (+0.04), CSII: 37.22 (-2.00), LMAT: 8.60 (+0.03)
NxStage Kidney Care Brings Innovative Dialysis Options to Prince George County
PR Newswire - Tue Mar 31, 7:00AM CDT
NxStage® Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), today announced the opening of its Greenbelt, Maryland dialysis center, offering patients several flexible therapy options. Conveniently located just off the DC Beltway between Baltimore and Washington DC, the center boasts a team of highly trained medical staff committed to providing high quality, personalized and compassionate care to dialysis patients and their families.
NXTM: 19.40 (+0.04)
NxStage Medical to Present Positive Data on System One - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 5:37PM CDT
Massachusetts-based manufacturer of innovative dialysis products, NxStage Medical, Inc. (NXTM), will present four new abstracts demonstrating clinical results during the National Kidney Foundation's Spring Clinical Meeting in Dallas, TX.
CAPR: 7.25 (-0.75), SRDX: 26.53 (+0.03), NXTM: 19.40 (+0.04), ABAX: 63.62 (+0.31)
New Data Show Improved Survival, Reduced Cardiovascular Hospital Readmissions, and Increased Transplantation on Home Hemodialysis with the NxStage System One
PR Newswire - Wed Mar 25, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, today announced the presentation of four new abstracts demonstrating clinical outcomes during the National Kidney Foundation's Spring Clinical Meeting in Dallas, Texas. Three of the abstracts highlight improved survival, reduced cardiovascular hospital readmissions, and increased transplantation for daily home hemodialysis (DHHD) patients using the NxStage® System One(TM) versus other modalities. The fourth abstract details results from the Company's groundbreaking study that led to the clearance of the System One as the first and only hemodialysis machine cleared for home nocturnal hemodialysis (home NHD).
NXTM: 19.40 (+0.04)
NxStage Celebrates Second Annual National Home Hemodialysis Day
PR Newswire - Thu Mar 19, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, is proud to celebrate the second annual Home Hemodialysis Day today, March 19, 2015, during National Kidney Month. Observed annually on the third Thursday of March, this initiative is dedicated to raising awareness of home hemodialysis, including nocturnal therapy, with the NxStage® System One(TM) and empowering dialysis patients to choose a therapy that is right for them. This evening in Boston, the city's iconic Zakim Bridge will be lit green in support of NxStage's awareness efforts and to commemorate Home Hemodialysis Day.
NXTM: 19.40 (+0.04)
NxStage to Present Abstract on Home Nocturnal Therapy with System One at NKF 2015 Spring Clinical Meeting
PR Newswire - Mon Mar 16, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, today announced a late breaking abstract, "Home Nocturnal Hemodialysis with Low Dialysate Volume: A Cross-Over Study," outlining favorable outcomes for more frequent home hemodialysis patients who transitioned to home nocturnal hemodialysis with the NxStage® System One(TM). The National Kidney Foundation accepted the abstract for poster presentation during its 2015 Spring Clinical Meeting in Dallas, Texas.
NXTM: 19.40 (+0.04)
Insider Trading Alert - DOC, SYNC And NXTM Traded By Insiders
at The Street - Thu Mar 12, 9:45AM CDT
Stocks with insider trader activity include DOC, SYNC and NXTM
NXTM: 19.40 (+0.04), SYNC: 2.42 (-0.02), DOC: 17.60 (+0.08)
NxStage Medical (NXTM) Q4 Loss Narrower than Expected - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 7:49AM CST
Manufacturer of innovative dialysis products, NxStage Medical Inc. (NXTM), reported adjusted loss of 8 cents per share in the fourth quarter of 2014, narrower than the Zacks Consensus Estimate of loss by a couple of cents
NXTM: 19.40 (+0.04), ABAX: 63.62 (+0.31), LMNX: 16.10 (-0.18), AFFX: 12.44 (-0.16)
NxStage Medical's (NXTM) CEO Jeff Burbank on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Mar 03, 11:20AM CST
NXTM: 19.40 (+0.04)
Micron Products, Inc. Appoints Michael Collette as Vice President of Quality
GlobeNewswire - Mon Mar 02, 12:30PM CST
Micron Products, Inc. (Micron), a wholly-owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT:HRT), announced today it has appointed medical device industry professional Michael Collette as the Company's Vice President of Quality, effective February 16, 2015. Mr. Collette brings more than 25 years of extensive quality and regulatory experience to Micron, including a long career in medical device manufacturing. He has led quality systems for leading medical device manufacturers, including NxStage Medical, Cynosure, Vaupell Northeast Molding and Tooling, and Smiths Medical.
NXTM: 19.40 (+0.04), HRT: 6.90 (-0.04)
NxStage Medical Looks Healthy as Home Dialysis Grows
Dan Caplinger, The Motley Fool - Motley Fool - Thu Feb 26, 10:14AM CST
NxStage Medical's home dialysis treatment offers convenience. Source: NxStage. The incidence of chronic kidney disease and diabetes has risen sharply in the U.S. in recent years, and that has required many Americans to start receiving dialysis...
NXTM: 19.40 (+0.04)
NxStage Medical (NXTM) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 26, 7:55AM CST
NXTM: 19.40 (+0.04)
NxStage Medical beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 6:31AM CST
NXTM: 19.40 (+0.04)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 4:30PM CST
KSS: 74.59 (-2.19), HSNI: 65.31 (-0.13), LKQ: 25.58 (unch), ACIW: 22.27 (+0.14), CNP: 21.05 (+0.08), OGE: 32.45 (+0.02), GCAP: 9.81 (-0.06), MRGE: 6.04 (+0.06), CYBX: 62.89 (-0.30), KOP: 22.47 (+0.03), IRDM: 10.66 (-0.23), AES: 13.46 (+0.15), ONE: 2.76 (-0.01), FIG: 8.36 (+0.16), ITC: 36.18 (+0.12), MITL: 9.51 (-0.08), MBLY: 47.62 (+0.01), MDXG: 9.81 (-0.39), AMWD: 53.31 (+0.66), MGLN: 71.19 (-0.02), EXH: 34.16 (-0.45), FRO: 2.71 (-0.09), NXTM: 19.40 (+0.04), SEAS: 21.49 (+0.35), DDD: 27.23 (-2.92), AKRX: 55.24 (-0.68), EXLP: 26.72 (-0.28), CWEI: 56.75 (-0.35), HSC: 16.13 (-0.14), IQNT: 19.31 (+0.94), ARCC: 17.21 (+0.01), SNAK: 8.71 (-0.69), HEES: 24.49 (-1.09), SDRL: 11.39 (-0.26), NTLS: 5.42 (-0.15), NXST: 58.83 (+0.20), SHLD: 41.13 (-0.52), CCG: 6.48 (-0.10), ICON: 26.77 (unch), FCH: 11.51 (-0.03), HAWK: 35.67 (-0.03), EME: 46.46 (-0.12), CHS: 17.60 (+0.02), BUD: 123.72 (+1.22), LTM: 71.46 (+0.02), AMCX: 76.75 (+0.13), CNSL: 21.30 (+0.12), LPI: 14.72 (-0.32), GOGO: 21.65 (-0.27), SFY: 2.91 (-0.07), ANSS: 87.46 (-0.61), BDBD: 10.14 (-0.05), BIN: 28.56 (-0.27), CRI: 94.08 (-0.90), RHP: 60.22 (-0.17), ACTA: 14.74 (-0.01)
NxStage Kidney Care Brings Flexible Dialysis Therapy Options to North Orlando
PR Newswire - Wed Apr 22, 7:00AM CDT
NxStage® Kidney Care, Inc. (NxKC), a subsidiary of NxStage® Medical, Inc. (Nasdaq: NXTM), today announced the opening of its North Orlando, Florida dialysis center. The new clinic is owned and operated in partnership with Central Florida Kidney Centers, a nonprofit dialysis provider serving central Florida for over 42 years. Conveniently located in Casselberry, the center boasts a team of highly-trained medical personnel dedicated to providing high-quality, personalized and compassionate care to dialysis patients and their loved ones.
NXTM: 19.40 (+0.04)
Insider Trading Alert - AGIO, NXTM And EBIX Traded By Insiders
at The Street - Mon Apr 20, 9:48AM CDT
Stocks with insider trader activity include AGIO, NXTM and EBIX
NXTM: 19.40 (+0.04), EBIX: 29.77 (-0.21), AGIO: 107.04 (+3.28)
NxStage Medical Opens New Dialysis Center in Pittsburgh - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 1:00PM CDT
NxStage Medical Inc.'s (NXTM) Monroeville dialysis center will offer flexible therapies and high-quality personalized care to dialysis patients and their families.
SRDX: 26.53 (+0.03), NXTM: 19.40 (+0.04), CSII: 37.22 (-2.00), LMAT: 8.60 (+0.03)
NxStage Kidney Care Brings Dialysis Options to Pittsburgh Area
PR Newswire - Tue Apr 14, 7:00AM CDT
NxStage® Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), today announced the opening of its Monroeville, Pennsylvania dialysis center, offering local patients several flexible therapy options. Conveniently located in Allegheny County, the NxStage Kidney Care Pittsburgh team is comprised of highly trained medical staff committed to providing dialysis patients with high quality, personalized and compassionate care.
NXTM: 19.40 (+0.04)
Insider Trading Alert - KMG, NXTM And DRI Traded By Insiders
at The Street - Fri Apr 10, 9:05AM CDT
Stocks with insider trader activity include KMG, NXTM and DRI
NXTM: 19.40 (+0.04), KMG: 30.00 (unch), DRI: 67.01 (+1.20)
NxStage® to Report First Quarter 2015 Financial Results
PR Newswire - Tue Apr 07, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the first quarter ended March 31, 2015, on Wednesday, May 6, 2015, before the opening of the financial markets.
NXTM: 19.40 (+0.04)
NxStage Medical Opens New Dialysis Center in Maryland - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 5:31PM CDT
NxStage Kidney Care Inc., a subsidiary of NxStage Medical Inc. (NXTM) opened a dialysis center in Greenbelt, MD, focused on providing flexible therapies and high-quality personalized care to dialysis patients and their families.
SRDX: 26.53 (+0.03), NXTM: 19.40 (+0.04), CSII: 37.22 (-2.00), LMAT: 8.60 (+0.03)
NxStage Kidney Care Brings Innovative Dialysis Options to Prince George County
PR Newswire - Tue Mar 31, 7:00AM CDT
NxStage® Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), today announced the opening of its Greenbelt, Maryland dialysis center, offering patients several flexible therapy options. Conveniently located just off the DC Beltway between Baltimore and Washington DC, the center boasts a team of highly trained medical staff committed to providing high quality, personalized and compassionate care to dialysis patients and their families.
NXTM: 19.40 (+0.04)
NxStage Medical to Present Positive Data on System One - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 5:37PM CDT
Massachusetts-based manufacturer of innovative dialysis products, NxStage Medical, Inc. (NXTM), will present four new abstracts demonstrating clinical results during the National Kidney Foundation's Spring Clinical Meeting in Dallas, TX.
CAPR: 7.25 (-0.75), SRDX: 26.53 (+0.03), NXTM: 19.40 (+0.04), ABAX: 63.62 (+0.31)
New Data Show Improved Survival, Reduced Cardiovascular Hospital Readmissions, and Increased Transplantation on Home Hemodialysis with the NxStage System One
PR Newswire - Wed Mar 25, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, today announced the presentation of four new abstracts demonstrating clinical outcomes during the National Kidney Foundation's Spring Clinical Meeting in Dallas, Texas. Three of the abstracts highlight improved survival, reduced cardiovascular hospital readmissions, and increased transplantation for daily home hemodialysis (DHHD) patients using the NxStage® System One(TM) versus other modalities. The fourth abstract details results from the Company's groundbreaking study that led to the clearance of the System One as the first and only hemodialysis machine cleared for home nocturnal hemodialysis (home NHD).
NXTM: 19.40 (+0.04)
NxStage Celebrates Second Annual National Home Hemodialysis Day
PR Newswire - Thu Mar 19, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, is proud to celebrate the second annual Home Hemodialysis Day today, March 19, 2015, during National Kidney Month. Observed annually on the third Thursday of March, this initiative is dedicated to raising awareness of home hemodialysis, including nocturnal therapy, with the NxStage® System One(TM) and empowering dialysis patients to choose a therapy that is right for them. This evening in Boston, the city's iconic Zakim Bridge will be lit green in support of NxStage's awareness efforts and to commemorate Home Hemodialysis Day.
NXTM: 19.40 (+0.04)
NxStage to Present Abstract on Home Nocturnal Therapy with System One at NKF 2015 Spring Clinical Meeting
PR Newswire - Mon Mar 16, 7:00AM CDT
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, today announced a late breaking abstract, "Home Nocturnal Hemodialysis with Low Dialysate Volume: A Cross-Over Study," outlining favorable outcomes for more frequent home hemodialysis patients who transitioned to home nocturnal hemodialysis with the NxStage® System One(TM). The National Kidney Foundation accepted the abstract for poster presentation during its 2015 Spring Clinical Meeting in Dallas, Texas.
NXTM: 19.40 (+0.04)
Insider Trading Alert - DOC, SYNC And NXTM Traded By Insiders
at The Street - Thu Mar 12, 9:45AM CDT
Stocks with insider trader activity include DOC, SYNC and NXTM
NXTM: 19.40 (+0.04), SYNC: 2.42 (-0.02), DOC: 17.60 (+0.08)
NxStage Medical (NXTM) Q4 Loss Narrower than Expected - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 7:49AM CST
Manufacturer of innovative dialysis products, NxStage Medical Inc. (NXTM), reported adjusted loss of 8 cents per share in the fourth quarter of 2014, narrower than the Zacks Consensus Estimate of loss by a couple of cents
NXTM: 19.40 (+0.04), ABAX: 63.62 (+0.31), LMNX: 16.10 (-0.18), AFFX: 12.44 (-0.16)
NxStage Medical's (NXTM) CEO Jeff Burbank on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Mar 03, 11:20AM CST
NXTM: 19.40 (+0.04)
Micron Products, Inc. Appoints Michael Collette as Vice President of Quality
GlobeNewswire - Mon Mar 02, 12:30PM CST
Micron Products, Inc. (Micron), a wholly-owned subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT:HRT), announced today it has appointed medical device industry professional Michael Collette as the Company's Vice President of Quality, effective February 16, 2015. Mr. Collette brings more than 25 years of extensive quality and regulatory experience to Micron, including a long career in medical device manufacturing. He has led quality systems for leading medical device manufacturers, including NxStage Medical, Cynosure, Vaupell Northeast Molding and Tooling, and Smiths Medical.
NXTM: 19.40 (+0.04), HRT: 6.90 (-0.04)
NxStage Medical Looks Healthy as Home Dialysis Grows
Dan Caplinger, The Motley Fool - Motley Fool - Thu Feb 26, 10:14AM CST
NxStage Medical's home dialysis treatment offers convenience. Source: NxStage. The incidence of chronic kidney disease and diabetes has risen sharply in the U.S. in recent years, and that has required many Americans to start receiving dialysis...
NXTM: 19.40 (+0.04)
NxStage Medical (NXTM) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 26, 7:55AM CST
NXTM: 19.40 (+0.04)
NxStage Medical beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 6:31AM CST
NXTM: 19.40 (+0.04)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 4:30PM CST
KSS: 74.59 (-2.19), HSNI: 65.31 (-0.13), LKQ: 25.58 (unch), ACIW: 22.27 (+0.14), CNP: 21.05 (+0.08), OGE: 32.45 (+0.02), GCAP: 9.81 (-0.06), MRGE: 6.04 (+0.06), CYBX: 62.89 (-0.30), KOP: 22.47 (+0.03), IRDM: 10.66 (-0.23), AES: 13.46 (+0.15), ONE: 2.76 (-0.01), FIG: 8.36 (+0.16), ITC: 36.18 (+0.12), MITL: 9.51 (-0.08), MBLY: 47.62 (+0.01), MDXG: 9.81 (-0.39), AMWD: 53.31 (+0.66), MGLN: 71.19 (-0.02), EXH: 34.16 (-0.45), FRO: 2.71 (-0.09), NXTM: 19.40 (+0.04), SEAS: 21.49 (+0.35), DDD: 27.23 (-2.92), AKRX: 55.24 (-0.68), EXLP: 26.72 (-0.28), CWEI: 56.75 (-0.35), HSC: 16.13 (-0.14), IQNT: 19.31 (+0.94), ARCC: 17.21 (+0.01), SNAK: 8.71 (-0.69), HEES: 24.49 (-1.09), SDRL: 11.39 (-0.26), NTLS: 5.42 (-0.15), NXST: 58.83 (+0.20), SHLD: 41.13 (-0.52), CCG: 6.48 (-0.10), ICON: 26.77 (unch), FCH: 11.51 (-0.03), HAWK: 35.67 (-0.03), EME: 46.46 (-0.12), CHS: 17.60 (+0.02), BUD: 123.72 (+1.22), LTM: 71.46 (+0.02), AMCX: 76.75 (+0.13), CNSL: 21.30 (+0.12), LPI: 14.72 (-0.32), GOGO: 21.65 (-0.27), SFY: 2.91 (-0.07), ANSS: 87.46 (-0.61), BDBD: 10.14 (-0.05), BIN: 28.56 (-0.27), CRI: 94.08 (-0.90), RHP: 60.22 (-0.17), ACTA: 14.74 (-0.01)
